Hepatitis E, IgG Antibodies. Screening

Clinical information

Diagnostic Utility:

This involves the qualitative detection of IgG antibodies against the hepatitis E virus (HEV) and its determination is useful for:

• Identification of individuals who have been exposed to the Hepatitis E virus

Method:

ELISA

Reference Values

Possible results: Positive and Negative.

Diagnostic Algorithm:

Not applicable.

Response Time:

Maximum 30 working days.

Specimen information

Sample: Serum and/or plasma
Tube: 1-5 mL aliquots, plasma tubes with EDTA, sodium citrate, or heparin as anticoagulant and/or serum tubes with and without gel separator.
Minimum essential volume: 1ml
Stability:

• At room temperature: ≤ 4 days
• Refrigerated 2-8 ºC: ≤ 14 days
• Sample frozen at or below -20ºC: 10 years

Transport instructions: Preferably at room temperature and/or refrigerated if they are whole blood tubes and frozen if they are serum and/or plasma aliquots.

Reason for rejection: Samples inactivated by heat, icteric, hemolyzed, and lipemic samples.

Administrative information

BST Code: 0402
Test Description: Hepatitis E Antibodies IgG. Screening
Synonyms: anti-HEV IgG
Section: Transfusion Safety Laboratory
BST Rates: Check the updated rates here.

Profiles:

Test 0402 Hepatitis E, Antibodies IgG. Screening is requested with the profile:

References

• Inserts kits test MICROGEN DIAGNOSTIK recomWell HEV IgG

Quality

BST holds ISO 9001, ISO 14001, and OSHAS 18001 quality certifications, as well as the European Excellence 500+ seal. BST is accredited by CAT, JACIE-FACT, FACT-NETCORD, and EFI, and complies with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) guidelines.